We would agree from a UK perspective. qSOFA, in as yet unpublished studies I 
and others have seen, is not superior to our existing national early warning 
score (NEWS) in identifying patients requiring intervention- it is almost too 
specific.

R

Dr Ron Daniels BEM
CEO: UK Sepsis Trust and Global Sepsis Alliance
Clinical Adviser to NHS England

Sent on the move from my iPhone, excuse brevity!

On 28 Sep 2016, at 09:18, Martie Mattson 
<[email protected]<mailto:[email protected]>> wrote:

I have some concerns with the using the qSOFA to determine necessity for 
further screening.  Since 2006, I have worked with over 15 hospitals in 
California and Washington to implement screening, and although I never 
collected any formal data regarding this, it is my stong impression that in the 
younger, generally healthier population who get septic, change in mental status 
and decreased blood pressure are more often later signs.  The younger person 
usually has a greater ability to compensate, so these signs don't show up until 
later in the septic process and we would miss the opportunity for early 
recognition that has been proven to reduce mortality.

I strongly feel that this tool needs to be validated concurrently in the 
inpatient and outpatient area clinical area before it is use is recommended as 
the best tool.



Martie Mattson, RN, MSN, CNS
Critical Care Consultant and Educator
Surviving Sepsis Protocol Implementation
[email protected]<mailto:[email protected]>
(415) 412-2364



On Thu, Sep 22, 2016 at 10:49 AM, Reid, Kathryn S. 
<[email protected]<mailto:[email protected]>> wrote:
Has anyone developed a successful marriage of the two screenings yet?  If so, I 
would be very interested in how you are using both effectively to capture the 
core measure population as well as use the new recommendations.

Thanks,
Katie

Katie Swink Reid, MPH, CPHQ
Quality Consultant
Performance Improvement & Outcomes
Inova Loudoun Hospital
44045 Riverside Parkway
Leesburg,VA 20176
T 703-858-6367<tel:703-858-6367> | 
[email protected]<mailto:[email protected]>

[http://inova.monigle2.net/images/email_sig/inova_email_logo.jpg]<http://www.inova.org/>

This communication may contain confidential and/or privileged information. 
Additionally, this communication may contain protected health information (PHI) 
that is legally protected from inappropriate disclosure by the Privacy 
Standards of the Health Insurance Portability and Accountability Act (HIPAA) 
and relevant Virginia Laws. If you are not the intended recipient, please note 
that any dissemination, distribution or copying of this communication is 
strictly prohibited. If you have received this message in error, you should 
notify the sender immediately by telephone or by return e-mail and delete this 
message from your computer. Direct questions to the Chief Privacy Officer at 
703-205-2337<tel:703-205-2337>.


_______________________________________________
Sepsisgroups mailing list
[email protected]<mailto:[email protected]>
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org


_______________________________________________
Sepsisgroups mailing list
[email protected]<mailto:[email protected]>
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

Reply via email to